Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats.
Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats.
复制标题
DOI:
10.1038/bjc.2013.830
复制
发表时间:
2014-03-04
影响因子:
8.8
通讯作者:
Brown JM
中科院分区:
文献类型:
--
作者:
Walters MJ;Ebsworth K;Berahovich RD;Penfold ME;Liu SC;Al Omran R;Kioi M;Chernikova SB;Tseng D;Mulkearns-Hubert EE;Sinyuk M;Ransohoff RM;Lathia JD;Karamchandani J;Kohrt HE;Zhang P;Powers JP;Jaen JC;Schall TJ;Merchant M;Recht L;Brown JM
In experimental models of glioblastoma multiforme (GBM), irradiation (IR) induces local expression of the chemokine CXCL12/SDF-1, which promotes tumour recurrence. The role of CXCR7, the high-affinity receptor for CXCL12, in the tumour's response to IR has not been addressed. We tested CXCR7 inhibitors for their effects on tumour growth and/or animal survival post IR in three rodent GBM models. We used immunohistochemistry to determine where CXCR7 protein is expressed in the tumours and in human GBM samples. We used neurosphere formation assays with human GBM xenografts to determine whether CXCR7 is required for cancer stem cell (CSC) activity in vitro. CXCR7 was detected on tumour cells and/or tumour-associated vasculature in the rodent models and in human GBM. In human GBM, CXCR7 expression increased with glioma grade and was spatially associated with CXCL12 and CXCL11/I-TAC. In the rodent GBM models, pharmacological inhibition of CXCR7 post IR caused tumour regression, blocked tumour recurrence, and/or substantially prolonged survival. CXCR7 expression levels on human GBM xenograft cells correlated with neurosphere-forming activity, and a CXCR7 inhibitor blocked sphere formation by sorted CSCs. These results indicate that CXCR7 inhibitors could block GBM tumour recurrence after IR, perhaps by interfering with CSCs.
登录
查看更多内容
影响因子:
56.9
作者:
Asahara, T;Murohara, T;Isner, JM
通讯作者:
Isner, JM
影响因子:
64.5
作者:
Eyler CE;Wu Q;Yan K;MacSwords JM;Chandler-Militello D;Misuraca KL;Lathia JD;Forrester MT;Lee J;Stamler JS;Goldman SA;Bredel M;McLendon RE;Sloan AE;Hjelmeland AB;Rich JN
通讯作者:
Rich JN
DOI:
10.4161/cc.8.20.9701
发表时间:
2009-10-15
期刊:
Cell cycle (Georgetown, Tex.)
影响因子:
--
作者:
Heddleston JM;Li Z;McLendon RE;Hjelmeland AB;Rich JN
通讯作者:
Rich JN
DOI:
10.1084/jem.20102010
发表时间:
2011-02-14
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Cruz-Orengo L;Holman DW;Dorsey D;Zhou L;Zhang P;Wright M;McCandless EE;Patel JR;Luker GD;Littman DR;Russell JH;Klein RS
通讯作者:
Klein RS
影响因子:
50.3
作者:
Ahn, G-One;Brown, J. Martin
通讯作者:
Brown, J. Martin